Besifloxacin ophthalmic suspension 0.6%. [electronic resource]
Producer: 20100427Description: 83-97 p. digitalISSN:- 1179-1950
- Administration, Topical
- Anti-Bacterial Agents -- pharmacology
- Antifungal Agents -- pharmacology
- Aza Compounds -- pharmacology
- Azepines -- therapeutic use
- Colony Count, Microbial
- Conjunctivitis, Bacterial -- drug therapy
- DNA Gyrase -- metabolism
- DNA Topoisomerase IV -- metabolism
- Double-Blind Method
- Drug Administration Schedule
- Eye
- Fluoroquinolones -- therapeutic use
- Humans
- Methicillin Resistance
- Methicillin-Resistant Staphylococcus aureus
- Microbial Sensitivity Tests
- Moxifloxacin
- Ophthalmic Solutions -- therapeutic use
- Quinolines -- pharmacology
- Staphylococcal Infections -- drug therapy
- Staphylococcus aureus -- drug effects
- Streptococcus pneumoniae -- drug effects
- Suspensions -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.